Tag:

fatty liver

“Watch Video: Early Signs, Causes, and Prevention of Fatty Liver Disease You Shouldn’t Ignore”

by Dr. Shruthi R October 30, 2024

written by Dr. Shruthi R

Liver Problems: Fatty liver disease is becoming increasingly common, but if not identified in time, it can lead to severe health issues, including liver cancer. In this video, we will explore the early signs of fatty liver, its causes, and preventive measures.

Liver Problems: Understanding Fatty Liver Disease, Its Signs, Causes, and Prevention

Fatty liver disease, or hepatic steatosis, is a condition in which an excessive amount of fat builds up in the liver. This condition has become increasingly common due to lifestyle factors, dietary habits, and rising obesity rates worldwide. Though fatty liver disease itself may seem benign in its early stages, it can lead to severe complications, such as liver inflammation, fibrosis, cirrhosis, and in some cases, liver cancer if not managed appropriately. Addressing this issue requires a deep understanding of the early signs, causes, and preventive measures for fatty liver disease.

What is Fatty Liver Disease?

Fatty liver disease refers to the accumulation of excess fat in the liver cells, accounting for over 5–10% of the liver’s weight. A healthy liver typically has some fat, but excessive fat can interfere with liver function and eventually lead to a variety of health issues.

Fatty liver disease is primarily classified into two types:

Non-Alcoholic Fatty Liver Disease (NAFLD): This is one of the most common liver disorders in the world and is not related to alcohol consumption. NAFLD is usually caused by obesity, poor diet, and sedentary lifestyles.
Alcoholic Fatty Liver Disease (AFLD): This condition is directly related to excessive alcohol consumption. Alcohol overloads the liver, making it difficult for the liver cells to metabolize fats and leading to fat accumulation.

Early Signs of Fatty Liver Disease

The challenge with fatty liver disease lies in its “silent” nature; many people do not experience symptoms in the early stages. However, some early indicators can include:

Fatigue: Feeling excessively tired or experiencing a lack of energy can be one of the earliest signs of fatty liver disease.
Abdominal Discomfort: A dull or aching pain in the upper right part of the abdomen, where the liver is located, may be noticed.
Mild Weight Loss: Some individuals might experience unintended weight loss.
Loss of Appetite: Decreased appetite is also common and often goes unnoticed as a symptom of a liver problem.
Enlarged Liver: A doctor may detect an enlarged liver during a physical exam.
Dark Urine or Pale Stool: Changes in urine and stool color may indicate liver strain.

In more advanced stages, additional symptoms may emerge, such as jaundice (yellowing of the skin and eyes), swelling in the legs or abdomen, and confusion due to a buildup of toxins in the blood.

Causes of Fatty Liver Disease

Several factors contribute to the development of fatty liver disease, some of which are controllable while others are not:

Obesity: Obesity is a major risk factor. Excess fat, especially abdominal fat, correlates with increased fat deposition in the liver.
Insulin Resistance and Type 2 Diabetes: When cells become resistant to insulin, the body tends to store more fat in the liver. People with diabetes are thus at a higher risk.
High Cholesterol and Triglyceride Levels: High levels of these fats in the blood are commonly linked to fatty liver.
Sedentary Lifestyle: Physical inactivity leads to increased fat storage in the liver and other areas of the body.
Poor Diet: Diets high in processed sugars, refined carbs, and unhealthy fats can contribute significantly to fat buildup in the liver.
Genetics: Certain genetic factors may predispose individuals to liver diseases.
Polycystic Ovary Syndrome (PCOS): Women with PCOS have a higher risk of fatty liver disease due to hormonal imbalances that may lead to insulin resistance.
Metabolic Syndrome: People with metabolic syndrome—a combination of high blood pressure, high blood sugar, excess body fat, and abnormal cholesterol levels—are at a heightened risk for fatty liver.

The Progression of Fatty Liver Disease

If left unchecked, fatty liver disease can progress through several stages:

Simple Fatty Liver (Steatosis): In this stage, fat accumulation is present, but there is little to no inflammation or liver cell damage.
Non-Alcoholic Steatohepatitis (NASH): In this more severe form, fat buildup is accompanied by liver cell inflammation and damage. NASH is linked to a higher risk of developing cirrhosis and liver cancer.
Fibrosis: With prolonged inflammation, scar tissue forms in the liver, impairing liver function.
Cirrhosis: This is the final, irreversible stage where extensive scar tissue has developed, affecting the liver’s ability to function properly. Cirrhosis can lead to liver failure or liver cancer.

Preventive Measures and Lifestyle Modifications

Taking steps to prevent or reverse fatty liver disease, especially in its early stages, can make a significant difference. Some key measures include:

Adopting a Balanced Diet: A diet rich in whole foods—such as fruits, vegetables, whole grains, lean proteins, and healthy fats—can prevent fat buildup in the liver. The Mediterranean diet is often recommended for liver health as it includes healthy fats, fiber, and antioxidants.
Maintaining a Healthy Weight: Regular exercise and portion control are vital in preventing obesity and reducing fat accumulation in the liver.
Regular Physical Activity: Exercise helps improve insulin sensitivity and reduces overall body fat, which indirectly reduces fat buildup in the liver.
Limiting Sugar Intake: Reducing refined sugars and avoiding sugary drinks can prevent spikes in blood sugar and fat storage in the liver.
Avoiding Alcohol Consumption: For those at risk of liver disease, reducing or eliminating alcohol can be highly beneficial.
Monitoring Cholesterol and Triglyceride Levels: Regular check-ups and dietary adjustments help manage cholesterol levels, reducing the risk of fatty liver disease.
Managing Diabetes: Keeping blood sugar levels under control helps reduce the likelihood of fat buildup in the liver.
Consulting with Healthcare Providers: Regular health screenings and consultations can help detect early signs and take preventive action before the disease progresses.

Diagnosis of Fatty Liver Disease

Several diagnostic tools are available to detect fatty liver disease:

Blood Tests: Liver function tests (LFTs) assess levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Elevated levels can indicate liver inflammation or damage.
Ultrasound: A liver ultrasound is a common imaging test to detect fat accumulation in the liver.
FibroScan or Elastography: This test measures liver stiffness, which can indicate scarring or fibrosis.
CT Scan or MRI: These imaging techniques provide detailed views of the liver and can help identify fat accumulation.
Liver Biopsy: In severe cases, a liver biopsy may be required to determine the extent of liver damage. This involves extracting a small tissue sample for analysis.

Potential Complications of Untreated Fatty Liver Disease

Fatty liver disease can lead to a range of serious complications if not managed in time:

Liver Inflammation and NASH: Chronic inflammation can lead to NASH, which is a serious form of non-alcoholic fatty liver disease.
Fibrosis and Cirrhosis: With continued inflammation, fibrosis and cirrhosis can develop. Cirrhosis is irreversible and can cause liver failure.
Liver Cancer: People with cirrhosis are at an increased risk of developing hepatocellular carcinoma, a primary type of liver cancer.
Heart Disease: Since fatty liver disease is often associated with obesity, diabetes, and high cholesterol, there is an increased risk of cardiovascular disease.

Current Treatments and Advances

Currently, there are no FDA-approved medications specifically for NAFLD, but research is underway. Treatment usually focuses on managing symptoms and risk factors:

Lifestyle Modifications: Diet and exercise are the primary recommendations for managing fatty liver disease.
Medications for Related Conditions: Managing diabetes, high cholesterol, and high blood pressure can indirectly improve liver health.
Experimental Treatments: Some drugs targeting liver inflammation and fibrosis are being studied, and there are hopeful signs for future treatment options.

Future Outlook: The Importance of Early Detection and Awareness

As the prevalence of fatty liver disease continues to rise, early detection and lifestyle modifications are essential to preventing serious complications. Increased awareness can empower people to take preventive measures and make lifestyle changes that protect liver health. Educating people about the risks of fatty liver disease, the importance of a balanced diet, and the need for regular exercise can be pivotal in addressing this health crisis on a larger scale.

Fatty liver disease is a preventable yet potentially severe condition that can lead to life-threatening complications if not managed in time. By recognizing early signs, understanding the causes, and making the necessary lifestyle adjustments, individuals can significantly reduce their risk and promote better liver health. Working closely with healthcare providers, focusing on healthy lifestyle choices, and being vigilant about liver health can prevent the progression of fatty liver disease and protect against long-term liver complications, including liver cancer.

October 30, 2024 0 comment

Air Pollution and Liver Health: Understanding the Link Between Toxic Air and Metabolic-Associated Fatty Liver Disease

Medical News

AIR POLLUTION AND LIVER HEALTH: UNDERSTANDING THE LINKED BETWEEN TOXIC AIR AND METABOLIC-ASSOCIATED FATTY LIVER DISEASE

by Anshika Mishra October 23, 2024

written by Anshika Mishra

Air pollution has long been recognized as a significant public health concern due to its detrimental effects on respiratory and cardiovascular health. However, emerging evidence now points to its impact on other organs, particularly the liver. Metabolic-associated fatty liver disease (MAFLD), which affects nearly a quarter of the global population, has recently been linked to long-term exposure to air pollution. This revelation adds another layer of complexity to the already challenging issue of managing and preventing liver diseases.

Research shows that air pollution, specifically fine particulate matter and other airborne toxins, may play a role in the onset and progression of liver diseases such as MAFLD. The situation is exacerbated in populations with unhealthy lifestyle habits, such as smoking, excessive alcohol consumption, and high-fat diets, as well as in individuals with central obesity.

A large-scale epidemiological study conducted in China has provided valuable insights into how prolonged exposure to polluted air can trigger metabolic and inflammatory changes in the liver, making this issue a pressing global health concern.

Liver Diseases and Their Growing Global Burden

Liver diseases encompass a wide range of conditions, with MAFLD (formerly known as non-alcoholic fatty liver disease, or NAFLD) being one of the most prevalent. MAFLD refers to the accumulation of fat in the liver that is not caused by excessive alcohol consumption but is instead associated with metabolic dysfunction. It has become a significant public health problem due to its association with obesity, type 2 diabetes, and metabolic syndrome. The incidence of MAFLD has risen sharply since the 1980s, primarily due to lifestyle changes, increasing urbanization, and the rising prevalence of obesity.

MAFLD can progress to more severe liver conditions such as non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and even liver cancer. In the advanced stages, it may lead to liver failure or the need for a liver transplant. This disease is also closely linked with other metabolic disorders, such as insulin resistance and cardiovascular diseases, further amplifying its health burden.

In Asia, the prevalence of MAFLD increased dramatically between 2012 and 2017, affecting nearly 40% of the population. This rise mirrors global trends and highlights the growing impact of lifestyle factors such as sedentary behavior, poor diet, and increasing exposure to environmental pollutants. Alarmingly, MAFLD has also become a leading cause of liver-related mortality, emphasizing the need for better understanding and management of its risk factors.

How Air Pollution Contributes to Liver Disease: Insights from Animal and Human Studies

Air pollution consists of a mixture of harmful substances, including particulate matter (PM), nitrogen oxides (NOx), ozone (O3), and volatile organic compounds (VOCs). Among these, fine particulate matter (PM2.5), which is less than 2.5 micrometers in diameter, poses the most significant risk to human health because of its ability to penetrate deep into the lungs and enter the bloodstream. Once in the bloodstream, these pollutants can affect various organs, including the liver.

Animal studies have consistently demonstrated the detrimental effects of air pollution on liver health. For instance, exposure to fine particulate matter has been shown to induce liver inflammation, oxidative stress, and lipid accumulation, all of which contribute to the development of a NASH-like phenotype. These studies suggest that pollutants may disrupt the liver’s metabolic processes, impair glucose metabolism, and promote hepatic fibrogenesis, which is the formation of excess fibrous tissue in the liver. This progression can lead to scarring and the eventual development of cirrhosis.

The mechanisms through which air pollution affects the liver are complex and multifaceted. One possible explanation is that pollutants trigger a systemic inflammatory response, which in turn affects liver function. Chronic inflammation is a well-known contributor to the development of metabolic diseases, including MAFLD. Additionally, oxidative stress caused by air pollution may damage liver cells and promote fat accumulation in the liver, further exacerbating the disease process.

Building on the insights from animal research, human studies have begun to reveal similar patterns. For example, several epidemiological studies have reported an association between long-term exposure to air pollution and the development of MAFLD. One such study, published in the Journal of Hepatology, provides compelling evidence of this link in a large population of Chinese adults.

Discovering the Role of Air Pollution in MAFLD

A large-scale epidemiological study conducted in China sought to explore the relationship between air pollution and the risk of MAFLD. The study, based on the China Multi-Ethnic Cohort (CMEC), involved nearly 90,000 adults from south-west China who were enrolled between 2018 and 2019. This cohort provided a unique opportunity to investigate how environmental factors, such as air pollution, interact with individual lifestyle habits and metabolic health.

The CMEC study collected extensive data on participants, including sociodemographic information, lifestyle habits (such as smoking, alcohol consumption, and diet), and health-related history. In addition, trained staff assessed various biological markers through biosamples (blood, urine, and saliva), anthropometric measurements (such as body mass index and waist circumference), and imaging data to evaluate liver health.

The findings revealed that long-term exposure to ambient air pollution, particularly fine particulate matter (PM2.5), was associated with a higher risk of developing MAFLD. The effects were more pronounced in certain subgroups, such as men, smokers, alcohol drinkers, and individuals who consumed a high-fat diet. These individuals appeared to be more vulnerable to the harmful effects of air pollution on liver health, suggesting that lifestyle factors and existing metabolic risk profiles may exacerbate the impact of environmental exposures.

One of the key findings from the study was the interaction between central obesity and air pollution. Individuals with excess fat accumulation in the abdominal area were particularly susceptible to the adverse effects of air pollution. This is concerning given the rising rates of obesity worldwide, as it suggests that an already vulnerable population is at heightened risk of developing liver disease when exposed to polluted air.

Implications for Public Health and Future Directions

The study’s findings underscore the importance of recognizing air pollution as a modifiable risk factor for MAFLD. Given the increasing prevalence of MAFLD globally, particularly in rapidly urbanizing regions like China, there is an urgent need for public health interventions that address both environmental and lifestyle factors. Reducing exposure to air pollution, especially in high-risk populations, could significantly lower the burden of liver disease.

Public awareness of air quality and its potential health impacts is crucial. Individuals, particularly those with metabolic risk factors such as obesity or diabetes, should be encouraged to monitor air pollution levels in their surroundings and take precautions to minimize exposure, such as staying indoors on days with high pollution or using air purifiers. Additionally, policymakers should prioritize measures to reduce air pollution, including stricter regulations on industrial emissions, vehicular exhaust, and other sources of fine particulate matter.

The growing body of evidence linking air pollution to liver diseases like MAFLD highlights the need for a comprehensive approach to tackling this global health challenge. By addressing both environmental and lifestyle risk factors, we can reduce the burden of liver disease and improve the overall health and well-being of populations worldwide.

October 23, 2024 0 comment

Uncategorized

Brain health is negatively impacted by fatty liver disease: Study

by Medically Speaking Team January 5, 2023

written by Medically Speaking Team

In a study examining the connection between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, researchers at the Roger Williams Institute of Hepatology, affiliated with King’s College London and the University of Lausanne, found that an accumulation of fat in the liver results in a reduction in oxygen to the brain and inflammation of brain tissue, both of which have been linked to the onset of severe brain diseases. NAFLD affects more than 80% of morbidly obese patients and around 25% of the general population.

This study is thought to be the first to definitively correlate NAFLD with brain degradation and identify a possible treatment target. Several studies have documented the detrimental impact that an improper diet and obesity may have on brain function. Inserm, the French National Institute of Health and Medical Research, and the University of Poitiers collaborated on the study, which entailed giving mice two alternative diets. A diet meant to imitate one made up of processed foods and sugary drinks was given to one half of the rats, while the other half received calories that were 55% fat.

Researchers compared these diets’ effects on the body, and more especially, on the liver and the brain, after 16 weeks of testing. All of the mice who consumed the greater amounts of fat were discovered to be obese, have NAFLD, insulin resistance, and cognitive impairment. The University of Lausanne and Foundation for Liver Research-funded study also revealed that mice with NAFLD had reduced oxygen levels in their brains. This is owing to the disease’s effects on the quantity and thickness of brain blood arteries, which reduce the amount of oxygen delivered to the tissue, as well as the fact that some cells demand more oxygen when the brain is inflamed.

Additionally, these mice displayed depressive symptoms and were more agitated.
In contrast, the mice on the healthy diet did not have NAFLD or insulin resistance, exhibited normal behaviour, and had a fully functional brain.

“It is very concerning to see the effect that fat accumulation in the liver can have on the brain, especially because it often starts off mild and can exist silently for many years without people knowing they have it,” said lead author Dr Anna Hadjihambi, sub-team lead in the Liver-Brain Axis group at the Roger Williams Institute of Hepatology and honorary lecturer at King’s College London.

Monocarboxylate Transporter 1 (MCT1), a protein that specialises in the transfer of energy substrates utilised by numerous cells for their appropriate function, was bred into mice with lower amounts in an effort to counteract the harmful effect that NAFLD has on the brain. These mice were protected against both diseases when given the same unhealthy diet high in fat and sugar as those in the previous trial. They showed no signs of brain malfunction and did not accumulate fat in the liver.

“Identifying MCT1 as a key element in the development of both NAFLD and its associated brain dysfunction opens interesting perspectives,” said Professor Luc Pellerin, director of the Inserm U1313 research unit at the University of Poitiers in France and senior researcher in the study. “It highlights potential mechanisms at play within the liver-brain axis and points to a possible therapeutic target.”

Dr Hadjihambi added: “This research emphasises that cutting down the amount of sugar and fat in our diets is not only important for tackling obesity, but also for protecting the liver to maintain brain health and minimise the risk of developing conditions like depression and dementia during ageing, when our brain becomes even more fragile.

January 5, 2023 0 comment

Uncategorized

Relation between liquid fructose intake and fatty liver disease

by Medically Speaking March 5, 2022

written by Medically Speaking

A high-fat diet is insufficient to produce fatty liver disease in the short run. When this diet is paired with the use of liquid fructose-sweetened drinks, the buildup of lipids in the liver is accelerated, and hypertriglyceridemia, a cardiovascular risk factor, can develop. Professor Juan Carlos Laguna of the Faculty of Pharmacy and Food Sciences, the Institute of Biomedicine of the University of Barcelona (IBUB), and the Physiopathology of Obesity and Nutrition Networking Biomedical Research Centre led a study on a mouse experimental model, which was published in the journal Molecular Nutrition and Food Research.

Researchers Aleix Sala-Vila and Iolanda Lázaro of the Hospital del Mar Medical Research Institute (IMIM) and José Rodrguez-Morató of IMIM-Hospital del Mar and MELIS-Pompeu Fabra University, among others, collaborated on the study.

Lipid metabolism and Fructose

In the food sector, fructose is one of the most widely used sweeteners. Corn syrup, a product formed from this gramineae, is used to make this simple sugar (monosaccharide). Despite scientific data linking fructose to metabolic illnesses, which are risk factors for cardiovascular pathologies, the food industry uses it to sweeten drinks, sauces, and processed meals due to its high sweetener power and low manufacturing costs.

The influence of fructose on the rise in fatty acid production in the liver, according to the current study, is more important than the external introduction of lipids through the food. “In high-fat diets which are supplemented with liquid fructose, this monosaccharide is able to induce an increase in the de novo lipogenesis — that is, the formation of fats through sugar — and an inhibition of the lipid oxidation in the liver,” says Professor Juan Carlos Laguna, from the Department of Pharmacology, Toxicology and Therapeutical Chemistry.

“Fructose intake, in particular, has a direct impact on the expression and activity of the nuclear factor ChREBP. This factor, once activated, promotes an increase in the production of enzymes that govern fatty acid synthesis in the liver “He keeps going. “At the same time, fructose consumption lowers the activity of the nuclear receptor PPARalfa, which is in charge of regulating the expression of genes that code for enzymes involved in fatty acid oxidation (mitochondrial and peroxisome) in the liver.” As indicated in the preclinical study, the formation of the fatty liver is caused by a combination of dietary saturated fat and activation of endogenous fatty acid production. “Moreover, unlike high-fat diets, we are describing for the first time that fructose increases the expression of the PNPLA3 protein, which is linked to the appearance of hypertriglyceridemia, a risk factor for cardiovascular diseases,” says Nria Roglans, co-author of the study and a member of the Department.

Fatty liver disease in humans

Several epidemiologic studies have linked the intake of fructose-sweetened beverages to non-alcoholic fatty liver disease (NAFLD), a condition for which no particular pharmaceutical treatment exists. De novo lipogenesis provides up to 30% of the lipids deposited in the liver in these individuals, but in healthy persons, this synthesis contributes just 5% of hepatic lipids.

The animal model developed by the researchers might be useful in the development of future medications to treat non-alcoholic fatty liver disease (NAFLD). “The endogenous production of lipids in the liver is greater in patients with this disease than in healthy people. As a result, the consequences revealed in this study might also occur in people “Take notice of the experts.

“Unfortunately, as they go on to say, fatty liver is the precursor to more severe diseases including steatohepatitis and cirrhosis. Although certain slight unspecific digestive issues may emerge in some cases, it is a symptomless disease. For the time being, there is no effective treatment for this condition other than a good diet and regular physical activity.”

Only when fructose is consumed in liquid form can the effects reported in the research be observed. “In the case of sweetened drinks, fructose is rapidly absorbed and rapidly enters the liver, causing the metabolic changes outlined. To make a contrast, consider the look of a fructose overdose when consumed in sweetened beverages “The team makes a point.

“When we eat fruit, however, the quantity of fructose we consume is far smaller than when we drink a sweetened beverage. The chewing process, as well as the presence of other constituents in the fruit, such as fibre, inhibits fructose absorption and delivery to the liver “The authors sum up their findings.

March 5, 2022 0 comment

Uncategorized

Naturopathic Tips to Address Fatty Liver Disease

by Dr. Shanmugam August 19, 2021

written by Dr. Shanmugam

By Shanmugam Asst CMO, Jindal Naturecure Institute

The liver is the largest organ inside the body that helps digestion of food, energy storage, and removal of toxic substances. Fatty liver disease happens to be a condition where excess fat deposits inside the liver. The fatty deposits interfere with the liver’s normal functioning and slow down the process of bile and insulin production necessary for various body functions. Excess amounts of fat in the liver can be worrisome, which can lead to permanent scarring and ultimately leading to liver failure.

Types of Fatty Liver Disease

There are two types of fatty liver disease – Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease. Non-alcoholic fatty liver disease is further categorised into 2 types – Simple Fatty Liver and Non-Alcoholic Steatohepatitis (NASH). In the case of NASH, the inflammation of the liver can lead to cancer or cirrhosis. On the other hand, Alcoholic Steatohepatitis is a condition that results from excessive consumption of alcohol. The liver releases toxic substances while breaking down alcohol which damages the organ’s cells and causes inflammation. Though globally, 25% of the adult population is affected by NAFLD, the prevalence rate is 9% to 32% in India.

Symptoms of Non-Alcoholic Fatty Liver Disease

Individuals of all age groups can be affected by non-alcoholic fatty liver disease. But, it is commonly observed in people within the age group of 40-50 who have certain pre-existing conditions like obesity, type 2 diabetes, high cholesterol, PCOS, sleep apnea, and metabolic syndrome. Usually, NAFLD doesn’t cause any symptoms; however, those with any of the above condition/s can experience enlarged spleen, abdominal swelling, enlarged blood vessels, yellowing of the skin and eyes, and red palms.

Naturopathic Treatment for Fatty Liver Disease

Naturopathic treatment encourages NASH patients to manage their comorbidities through various lifestyle changes, diet and supplements. Naturopathy recognises that every individual is different and requires a different treatment option. Here we look at some of the staples in a naturopathic treatment plan to deal with fatty liver disease.

Diet

Those with fatty liver disease must include plenty of organic fruits and green leafy vegetables in the diet. Proper nutrition can increase antioxidants and lessen the oxidative stress in the body leading to better health. If possible, it is always a good idea to opt for GMO-free (genetically modified organisms free) and organic products. If there is insulin resistance, one should also stay away from sugars.

Exercise

A study published in the ‘Alimentary Pharmacology and Therapeutics’ journal stated that daily exercise effectively reverses NAFLD. One can opt for exercise like yoga, running, cycling, swimming, etc., to maintain a healthy weight and stay fit. Regular exercise reduces fatty acid synthesis, increases fatty acid oxidation and prevents hepatocellular and mitochondrial damage.

Avoid Salted and Fried Foods

High in calories and fats, fried foods can make it a tough job for the liver to deal with them. With increased calorie intake, the chances of putting on weight also increases. Obese people are more at risk of developing fatty liver disease. The Journal of Agriculture and Food Chemistry has published a study stating that too much sodium harms the liver. Excess of sodium in the diet can lower cell division and increase cell deaths in the liver, which can cause liver fibrosis.

Natural Remedies

There are plenty of simple ingredients in everyday use that can bring positive outcomes and enhance the healing process of damaged liver.

Turmeric

Curcumin present in turmeric helps protect the liver cells from non-alcoholic fatty liver disease (NAFLD) when appropriately administered.

Cinnamon

Cinnamon has strong anti-inflammatory properties that are effective in bringing down the inflammation in the liver.

Indian Gooseberry

Amla or Indian Gooseberry is stuffed with antioxidants and Vitamin C that protects the liver from damage and cleans the toxins.

Apple Cider Vinegar

When it comes to home remedies, apple cider vinegar is a preferred choice since it has amazing detoxification properties. Apple Cider Vinegar works by helping the liver flush out the toxins that can interfere with the body’s normal functioning.

Stay Hydrated

When the body is well-hydrated, the toxins are easily removed from the body and blood flow is also improved. Daily 10-12 glasses of water are necessary to keep the body adequately hydrated.

August 19, 2021 0 comment